powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1396184354
David Hsieh
M.D.
Medical Oncology
Dallas,
TX
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
573
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
24
Brand share
41.5%
Top prescribed drugs
Prochlorperazine Maleate
54 claims
Hydrocodone/Acetaminophen
53 claims
Lenvatinib Mesylate
51 claims
Ondansetron Hcl
50 claims
Dexamethasone
39 claims
QUALITY · MIPS · 2024
Final MIPS score
82.9
Quality
70.2
Cost
72.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.33%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
6
By payment type
Travel and Lodging
$899
Food and Beverage
$312
Top paying entities
Travel and Lodging
$899
Food and Beverage
$312
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
143
Unique beneficiaries
—
Total services
299
Distinct HCPCS
2
Medicare payment
$33K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — bottom quintile (cohort median 4,999).
